Urology · Dallas, TX
NPI
1033138102
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3417 Gaston Ave, Ste 830
Dallas, TX, 75246
Phone (214) 826-6235
Groups this clinician bills Medicare through
Medicare paid, 2024
$266K
8,845 services
Medicare patients, 2024
763
Average age 75
Drug cost, 2024
$1.8M
2,845 prescriptions
Company payments, 2025
$613
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eric B Smith was code 81003 (clinical chemistry), 846 times for 581 patients. In total Eric B Smith billed 8,845 services in 84 codes, and Medicare paid $266K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81003 Clinical Chemistry | Office | 846 | 581 | $2.19 | $1,853 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 659 | 503 | $13.50 | $8,897 |
| 99213 Office E&M - Established | Office | 617 | 483 | $68.37 | $42K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 532 | 87 | $49.41 | $26K |
| 36415 Venipuncture Blood Collection | Office | 459 | 299 | $8.65 | $3,970 |
| 84153 Clinical Chemistry | Office | 430 | 276 | $18.02 | $7,749 |
| 99214 Office E&M - Established | Office | 253 | 221 | $96.96 | $25K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 224 | 25 | $141.12 | $32K |
| 51798 Ultrasound - Nonspecific | Office | 168 | 118 | $9.03 | $1,517 |
| 84154 Clinical Chemistry | Office | 162 | 116 | $18.02 | $2,919 |
| 87086 Bacterial Culture | Office | 143 | 100 | $7.78 | $1,113 |
| 87088 Bacterial Culture | Office | 130 | 75 | $7.78 | $1,012 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 113 | 54 | $40.84 | $4,615 |
| 84403 Clinical Chemistry | Office | 105 | 60 | $25.12 | $2,638 |
| 99204 Office E&M - New | Office | 95 | 95 | $131.04 | $12K |
By year: 2022 $201K for 9,396 services; 2023 $231K for 10,432 services; 2024 $266K for 8,845 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 846 | 581 | $2.19 | $1,853 |
| 36415 Venipuncture Blood Collection | 459 | 299 | $8.65 | $3,970 |
| 84153 Clinical Chemistry | 430 | 276 | $18.02 | $7,749 |
| 84154 Clinical Chemistry | 162 | 116 | $18.02 | $2,919 |
| 87086 Bacterial Culture | 143 | 100 | $7.78 | $1,113 |
| 87088 Bacterial Culture | 130 | 75 | $7.78 | $1,012 |
| 84403 Clinical Chemistry | 105 | 60 | $25.12 | $2,638 |
| 81001 Clinical Chemistry | 68 | 68 | $3.07 | $209 |
| 87077 Bacterial Culture | 53 | 41 | $7.80 | $413 |
| 87186 General Laboratory | 52 | 40 | $8.35 | $434 |
Medicare prescription drug claims, 2024
In 2024, the drug Eric B Smith prescribed most often to Medicare patients was Silodosin, with 858 prescriptions and refills. In total Eric B Smith wrote 2,845 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Silodosin Generic | 858 | 1,669 | 269 | $64K |
| Tamsulosin Hcl Generic | 257 | 652 | 84 | $3,559 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 171 | 399 | 49 | $4,609 |
| Myrbetriq Mirabegron | 145 | 211 | 35 | $93K |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 138 | 332 | 65 | $7,014 |
| Ciprofloxacin Hcl Generic | 127 | 127 | 112 | $656 |
| Gemtesa Vibegron | 118 | 206 | 32 | $98K |
| Tadalafil Generic | 116 | 244 | 27 | $10K |
| Levofloxacin Generic | 94 | 94 | 77 | $480 |
| Solifenacin Succinate Generic | 68 | 142 | 20 | $2,271 |
| Erleada Apalutamide | 55 | 55 | Under 11 | $791K |
| Tramadol Hcl Generic | 52 | 60 | 41 | $196 |
| Finasteride Generic | 44 | 130 | 16 | $700 |
| Desmopressin Acetate Generic | 43 | 73 | Under 11 | $2,684 |
| Orgovyx Relugolix | 41 | 41 | Under 11 | $105K |
Brand drugs: - claims; generic drugs: 2,394 claims; opioid claims: 107.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eric B Smith $613 ($613 in general payments such as food, travel and fees) from 14 companies. The largest payer was Novartis Pharmaceuticals Corporation with $114.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 4 | $114 |
| Astellas Pharma US Inc 4503.T | 5 | $103 |
| Pfizer Inc. PFE | 3 | $56.05 |
| Olympus America Inc. | 2 | $55.31 |
| Janssen Biotech, Inc. JNJ | 3 | $52.96 |
| Immunitybio, Inc. IBRX | 1 | $35.26 |
| Dendreon Pharmaceuticals LLC | 1 | $33.45 |
| Tempus AI, Inc TEM | 1 | $28.61 |
| Merck Sharp & Dohme LLC MRK | 1 | $27.37 |
| Innovation Technologies Inc | 1 | $24.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.